Skip to main content
Log in

Predicting pleural metastasis by detecting CD55 using an ultrasound-enhanced scintillation proximity assay

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

We used an ultrasound-enhanced scintillation proximity assay to accurately determine the levels of complement decay-accelerating factor (CD55) for the early detection and assessment of the progression of pleural metastatic lung cancer. We found that the expression of CD55 in metastatic tumor tissues is 2.8 times higher than that in the serum at the early stages. We also found that the concentration of CD55 in serum decreases with the progression of metastasis. These results suggest that CD55 is a potential biomarker for the prediction of pleural metastatic lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Agalioti T, Giannou AD (2015) Stathopoulos GT. Pleural involvement in lung cancer. J Thorac Dis 7(6):1021–1030

    PubMed  PubMed Central  Google Scholar 

  2. Psallidas I, Kalomenidis I, Porcel JM, Robinson BW (2016) Stathopoulos GT. Malignant pleural effusion: from bench to bedside. Eur Respir Rev 25:189–198

    Article  Google Scholar 

  3. Zhu K, Chen L, He C, Lang Y, Kong X, Qu C, Xu S (2020) Prediction of pleural invasion in challenging non-small-cell lung cancer patients using serum and imaging markers. Dis Markers. https://doi.org/10.1155/2020/6430459

    Article  PubMed  PubMed Central  Google Scholar 

  4. Morgensztern D, Waqar S, Subramanian J, Trinkaus K, Govindan R (2012) Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer. J Thorac Dis 7:1485–1489

    Google Scholar 

  5. Huang H, Wang T, Hu B, Pan C (2015) Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer. Ann Thorac Surg 99(4):1130–1139

    Article  Google Scholar 

  6. Dho SH, Kim SY, Chung C, Cho EH, Lee SY, Kim JY, Kim LK, Min SW, Lee J, Jung SH, Lim JC (2017) Development of a radionuclide-labeled monoclonal anti-CD55 antibody with theranostic potential in pleural metastatic lung cancer. Sci Rep 8:8960–8972

    Article  Google Scholar 

  7. Dho SH, Lim JC, Kim LK (2018) Beyond the role of CD55 as a complement component. Immune Netw 18(1):e11

    Article  Google Scholar 

  8. Mikesch JH, Schier K, Roetger A, Simon R, Buerger H, Brandt B (2006) The expression and action of decay-accelerating factor (CD55) in human malignancies and cancer therapy. Cell Oncol 28:223–232

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Ikeda JI, Morii E, Liu Y, Qiu Y, Nakamichi N, Jokoji R, Miyoshi Y, Noguchi S, Aozasa K (2008) Prognostic significance of CD55 expression in breast cancer. Clin Cancer Res 14:4780–4786

    Article  CAS  Google Scholar 

  10. Durrant LG, Chapman MA, Buckley DJ, Spendlove I, Robins RA, Armitage NC (2006) Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients. Cancer Immunol Immunother 52:638–642

    Article  Google Scholar 

  11. Vadrevu SK, Chintala NK, Sharma SK, Sharma P, Cleveland C, Riediger L (2014) Complement C5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche. Cancer Res 74(13):3454–3465

    Article  CAS  Google Scholar 

  12. Scicchitano MS, Dalmas DA, Boyce RW, Thomas HC, Frazier KS (2009) Protein extraction of formalin-fixed, paraffin-embedded tissue enables robust proteomic profiles by mass spectrometry. J Histochem Cytochem 57:849–860

    Article  CAS  Google Scholar 

  13. Shi SR, Liu C, Balgley BM, Lee C, Taylor CR (2006) Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry. J Histochem Cytochem 54:739–743

    Article  CAS  Google Scholar 

  14. Lee SY, Lim JC, Cho EH, Jung SH (2016) A new scintillation proximity assay-based approach for the detection of KRAS mutations. Radiochim Acta 104:59–65

    Article  CAS  Google Scholar 

  15. Lee SY, Lim JC, Cho EH, Lee SK, Jung SH (2019) Ultrasound-enhanced scintillation proximity assay for rapid diagnostics. Anal Biochem 570:51–55

    Article  CAS  Google Scholar 

  16. Yang S, Yang L, Teng L, Zhang S, Cui Y, Cao Y, Shi H (2018) Visceral pleural invasion by pulmonary adenocarcinoma ≤ 3 cm: the pathological correlation with pleural signs on computed tomography. J Thorac Dis 10(7):3992–3999

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by Korea Atomic Energy Research Institute: Development of Radioisotope Production and Application Technology [524430-20].

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to So-Young Lee.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, SY., Lim, JC., Cho, EH. et al. Predicting pleural metastasis by detecting CD55 using an ultrasound-enhanced scintillation proximity assay. J Radioanal Nucl Chem 327, 707–712 (2021). https://doi.org/10.1007/s10967-020-07559-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-020-07559-x

Keywords

Navigation